Range and Distribution of NT-proBNP Values in Stable Corrected Congenital Heart Disease of Various Types

Canadian Journal of Cardiology

Volumn 28, Issue 4, 2012, Pages 471-476

  Popelová, Jana ^a   Kotaška, Karel ^b   Černý, Štěpán ^a   Prokopová, Milena ^a   Rubáček, Miroslav ^a  

^a NA HOMOLCE HOSPITAL   (Czech Republic)

^b UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE;

ADULT; AORTA COARCTATION; ARTICLE; ATRIOVENTRICULAR SEPTAL DEFECT; BLOOD SAMPLING; COHORT ANALYSIS; CONGENITAL HEART DISEASE; CONTROLLED STUDY; EBSTEIN ANOMALY; FALLOT TETRALOGY; FEMALE; FONTAN PROCEDURE; GREAT VESSELS TRANSPOSITION; HEART ATRIUM SEPTUM DEFECT; HEART SURGERY; HEART VENTRICLE SEPTUM DEFECT; HUMAN; MAJOR CLINICAL STUDY; MALE; MUSTARD OPERATION; OUTPATIENT DEPARTMENT; PROTEIN BLOOD LEVEL; PULMONARY VALVE ATRESIA; PULMONARY VALVE STENOSIS; SENNING CORRECTION;

ADULT; FEMALE; FOLLOW-UP STUDIES; HEART DEFECTS, CONGENITAL; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; POSTOPERATIVE COMPLICATIONS; REFERENCE VALUES; YOUNG ADULT;

EID: 84863864174     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cjca.2012.01.015     Document Type: Article

References (25)

1. Dickstein K., Cohen-Solal A., Filippatos G., et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008. The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J 2008, 29:2388-2442.
2. Hunt S.A., Abraham W.T., Chin M.H., et al. 2009 Focused Update Incorporated into thetACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults. A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Developed in Collaboration With the International Society for Heart and Lung Transplantation. Circulation 2009, 119:e391-e479.
3. McKie P.M., Cataliotti A., Lahr B.D., et al. The prognostic value of N-terminal pro-B-type natriuretic peptide for death and cardiovascular events in healthy normal and A/B stage heart failure subjects. J Am Coll Cardiol 2010, 55:2140-2147.
4. Alehagen U., Dahlstrom U., Rehfeld J.F., Goetze J.P. Prognostic assessment of elderly patients with symptoms of heart failure by combining high-sensitivity troponin T and N-terminal pro-B-type natriuretic peptide measurments. Clin Chem 2010, 56:1718-1724.
5. Giannakoulas G., Dimopoulos K., Bolger A.P., et al. Usefulness of natriuretic peptide levels to predict mortality in adults with congenital heart disease. Am J Cardiol 2010, 105:869-873.
6. Gardner R.S., Ozalp F., Murday A.J., Robb S.D., McDonagh T.A. N-terminal pro-brain natriuretic peptide. A new gold standard in predicting mortality in patients with advanced heart failure. Eur Heart J 2003, 24:1735-1743.
7. Berger R., Huelsmann M., Strecker K., et al. B-type natriuretic peptide predicts sudden death in patients with chronic heart failure. Circulation 2002, 105:2392-2397.
8. Bolger A.P., Sharma R., Li W., et al. Neurohormonal activation and the chronic heart failure syndrome in adults with congenital heart disease. Circulation 2002, 106:92-99.
9. Bolger A.P., Coats A.J.S., Gatzoulis M.A. Congenital heart disease: the original heart failure syndrome. Eur Heart J 2003, 24:970-976.
10. Bolger A.P., Gatzoulis M.A. Towards defining heart failure in adults with congenital heart disease. Int J Cardiol 2004, 97:15-23.
11. Norozi K., Wessel A., Alpers V., et al. Incidence and risk distribution of heart failure in adolescents and adults with congenital heart disease after cardiac surgery. Am J Cardiol 2006, 97:1238-1243.
12. Koch A.M.E., Zink S., Singer H., Dittrich S. B-type natriuretic peptide levels in patients with functionally univentricular hearts after total cavopulmonary connection. Eur J Heart Fail 2008, 10:60-62.
13. Larsson D.A., Meurling C.J., Holmqvist F., Waktare J.E.P., Thilén U.J. The diagnostic and prognostic value of brain natriuretic peptides in adults with a systemic morphologically right ventricle or Fontan-type circulation. Int J Cardiol 2007, 114:345-351.
14. Oosterhof T., Tulevski I.I., Vliegen H.W., Spijkerboer A.M., Mulder B.J.M. Effects of volume and/or pressure overload secondary to congenital heart disease (tetralogy of Fallot or pulmonary stenosis) on right ventricular function using cardiovascular magnetic resonance and B-type natriuretic peptide levels. Am J Cardiol 2006, 97:1051-1055.
15. Dodge-Khatami A., Buchel E.V., Knirsch W., et al. Brain natriuretic peptide and magnetic resonance imaging in tetralogy with right ventricular dilatation. Ann Thorac Surg 2006, 82:983-988.
16. Gustafsson F., Steensgaard-Hansen F., Badskjaer J., et al. Diagnostic and prognostic performance of N-terminal proBNP in primary care patients with suspected heart failure. J Card Fail 2005, 11(suppl 5):S15-S20.
17. Hess G., Runkel S., Zdunek D., Hitzler W.E. N-terminal pro-brain natriuretic peptide (NT-proBNP) in healthy blood donors and in patients from general practitioners with and without a diagnosis of cardiac disease. Clin Lab 2005, 51:167-172.
18. Kotaska K., Popelova J., Tiserova M., et al. The relevance of brain natriuretic peptides investigation in various cardiovascular diseases. Biomed Pap med Fac Univ Palacky Olomouc Czech Repub 2006, 150:285-288.
19. Diller G.P., Dimopoulos K., Okonko D., et al. Exercise intolerance in adult congenital heart disease. Circulation 2005, 112:828-835.
20. Attenhofer Jost C.H., Oechslin E., Seifert B., et al. Remodelling after surgical repair of atrial septal defects within the oval fossa. Cardiology in the Young 2002, 12:506-512.
21. Muta H., Ishii M., Maeno Y., Akagi T., Kato H. Quantitative evaluation of the changes in plasma concentrations of cardiac natriuretic peptide before and after transcatheter closure of atrial septal defect. Acta Paediatr 2002, 91:649-652.
22. Hučín B. Pediatric Cardiac Surgery [in Czech] 2001, Grada Publishing, Praha.
23. Plymen C.M., Hughes M.L., Picaut N., et al. The relationship of systemic right ventricular function to ECG parameters and NT-proBNP levels in adults with transposition of the great arteries late after Senning or Mustard surgery. Heart 2010, 96:1569-1573.
24. Chow P.C., Cheung E.W., Chong C.Y., et al. Brain natriuretic peptide as a biomarker of systemic right ventricular function in patients with transposition of great arteries after atrial switch operation. Int J Cardiol 2008, 127:192-197.
25. Silversides C.K., Marelli A., Beauchesne, et al. Canadian Cardiovascular Society 2009 Consensus Conference on the management of adults with congenital heart disease: executive summary. Can J Cardiol 2010, 26:143-150.